Eli Lilly-backed Symic raises $30M round as it preps for a pivotal trial
Symic Bio has some big goals set out for the next year. There’s a registration trial to prepare for on the lead program, more work …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
